Establishes the Center for Autoimmune and Blood Disorder Research; allows for collaboration among medical professionals to provide insights and approaches to understanding autoimmune and blood disorder diseases and improving treatment methods; makes an appropriation therefor.
Establishes the Center for Autoimmune and Blood Disorder Research; allows for collaboration among medical professionals to provide insights and approaches to understanding autoimmune and blood disorder diseases and improving treatment methods; makes an appropriation therefor.
Establishes the eating disorders in children task force to study and create a standardized approach to, and develop best practices and guidelines for awareness, recognition, and treatment of eating disorders in children.
Develops comprehensive assessment centers for autism spectrum disorders; provides grants for their development and lays out reporting and research requirements.
Develops comprehensive assessment centers for autism spectrum disorders; provides grants for their development and lays out reporting and research requirements.
Provides standards for correctional facilities in relation to medication assisted treatment for opioid use disorders and the testing for opioid use when an individual is first incarcerated.
Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.
Establishes a drug-induced movement disorder screening education program; provides that the department shall develop such program to educate the public about the importance of screening for drug-induced movement disorders, develop and disseminate educational materials for healthcare providers regarding treatment for drug-induced movement disorders, and eliminate bias and reduction of stigma for people living with drug-induced movement disorders related to the treatment of mental health conditions.